Differential gene expression studies to explore the molecular pathophysiology of Down syndrome

被引:32
作者
Antonarakis, SE
Lyle, R
Chrast, R
Scott, HS
机构
[1] Univ Geneva, Sch Med, Ctr Med Univ, Div Med Genet, CH-1211 Geneva, Switzerland
[2] Salk Inst Biol Studies, La Jolla, CA 92037 USA
[3] Walter & Eliza Hall Inst Med Res, Genet & Bioinformat Div, Melbourne, Vic 3050, Australia
关键词
Down syndrome; animal model; gene expression; SAGE; microarray;
D O I
10.1016/S0165-0173(01)00103-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Trisomy 21, which causes Down syndrome, is the model human disorder due to the presence of a supernumerary chromosome. The completion of the sequence of chromosome 21 and the development of appropriate animal models now provide the molecular infrastructure and the reagents to elucidate the molecular mechanisms of the different phenotypes of Down syndrome. The study of the overexpression of single genes, and the dysregulation of global gene expression will enhance the understanding of the pathogenesis of the cognitive impairment of this syndrome. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:265 / 274
页数:10
相关论文
共 38 条
  • [1] Aylward EH, 1999, AM J PSYCHIAT, V156, P564
  • [2] Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse
    Baxter, LL
    Moran, TH
    Richtsmeier, JT
    Troncoso, J
    Reeves, RH
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (02) : 195 - 202
  • [3] Exploring the new world of the genome with DNA microarrays
    Brown, PO
    Botstein, D
    [J]. NATURE GENETICS, 1999, 21 (Suppl 1) : 33 - 37
  • [4] Characterization of transgenic mice with an increased content of chromosomal protein HMG-14 in their chromatin
    Bustin, M
    Alfonso, PJ
    Pash, JM
    Ward, JM
    Gearhart, JD
    Reeves, RH
    [J]. DNA AND CELL BIOLOGY, 1995, 14 (12) : 997 - 1005
  • [5] The mouse brain transcriptome by SAGE: Differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals
    Chrast, R
    Scott, HS
    Papasavvas, MP
    Rossier, C
    Antonarakis, ES
    Barras, C
    Davisson, MT
    Schmidt, C
    Estivill, X
    Dierssen, M
    Pritchard, M
    Antonarakis, SE
    [J]. GENOME RESEARCH, 2000, 10 (12) : 2006 - 2021
  • [6] Mice trisomic for a bacterial artificial chromosome with the single-minded 2 gene (Sim2) show phenotypes similar to some of those present in the partial trisomy 16 mouse models of Down syndrome
    Chrast, R
    Scott, HS
    Madani, R
    Huber, L
    Wolfer, DP
    Prinz, M
    Aguzzi, A
    Lipp, HP
    Antonarakis, SE
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (12) : 1853 - 1864
  • [7] MOUSE TRISOMY 16 AS AN ANIMAL-MODEL OF HUMAN TRISOMY 21 (DOWN SYNDROME) - PRODUCTION OF VIABLE TRISOMY 16[--] DIPLOID MOUSE CHIMERAS
    COX, DR
    SMITH, SA
    EPSTEIN, LB
    EPSTEIN, CJ
    [J]. DEVELOPMENTAL BIOLOGY, 1984, 101 (02) : 416 - 424
  • [8] DOWN SYNDROME, ALZHEIMERS-DISEASE AND THE TRISOMY-16 MOUSE
    COYLE, JT
    OSTERGRANITE, ML
    REEVES, RH
    GEARHART, JD
    [J]. TRENDS IN NEUROSCIENCES, 1988, 11 (09) : 390 - 394
  • [9] Deutsch S, 2001, GENOME RES, V11, P300
  • [10] OVEREXPRESSION OF LIVER-TYPE PHOSPHOFRUCTOKINASE (PFKL) IN TRANSGENIC-PFKL MICE - IMPLICATION FOR GENE DOSAGE IN TRISOMY-21
    ELSON, A
    LEVANON, D
    WEISS, Y
    GRONER, Y
    [J]. BIOCHEMICAL JOURNAL, 1994, 299 : 409 - 415